TLR9 and juvenile dermatomyositis: Interestingly, under these experimental conditions, TLR-9 antagonism and NAC, and to a lesser extent cGAS-STING inhibition, can also suppress ISG expression in PBMC from treatment naïve (pretreatment) JDM patients in vitro.